Portfolio company
Altos Labs
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Life Biosciences
This biotechnology company develops cellular rejuvenation therapies using epigenetic restoration to treat age-related diseases, such as optic neuropathies, for patients with chronic conditions.
clock.bio
This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.
Neotis
This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.
Rejuvenate Bio
The company develops gene therapies to treat age-related chronic diseases in humans and companion animals.
NewLimit
This biotechnology company develops epigenetic reprogramming medicines to restore cellular function and treat age-related diseases for patients.
Cellergy Therapeutics
This biotechnology company develops purified mitochondrial transplantation therapies to treat patients with neurodegenerative diseases, muscle degeneration and age-related conditions.
Rejuveron Life Sciences
This clinical-stage biotechnology company develops regenerative medicines and small-molecule therapies for patients with age-related diseases to improve healthspan and longevity.
Cirrus Therapeutics
This company develops gene and cell therapies to treat age-related macular degeneration and chronic vision loss for patients with blinding eye diseases.
